Evidence map›Paper›PMID 26938921›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2016

A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings.

B O Olusanya, I F Iskander, T M Slusher, R P Wennberg

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Patterns of acute bilirubin encephalopathy in Nigeria: a multicenter pre-intervention study.Journal of perinatology : official journal of the California Perinatal Association · 2018
    Article
  4. A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B O OlusanyaCentre for Healthy Start Initiative, Lagos, Nigeria.
I F IskanderDepartment of Pediatrics, Cairo University, Cairo, Egypt.
T M SlusherHennepin County Medical Center, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
R P WennbergDepartment of Pediatrics, University of Washington, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late presentation and ineffective phototherapy account for excessive rates of avoidable exchange transfusions (ETs) in many low- and middle-income countries. Several system-based constraints sometimes limit the ability to provide timely ETs for all infants at risk of kernicterus, thus necessitating a treatment triage to optimize available resources. This article proposes a practical priority-setting model for term and near-term infants requiring ET after the first 48 h of life. The proposed model combines plasma/serum bilirubin estimation, clinical signs of acute bilirubin encephalopathy and neurotoxicity risk factors for predicting the risk of kernicterus based on available evidence in the literature.

Indexed as

Hyperbilirubinemia, NeonatalKernicterusNeurotoxicity SyndromesPatient Care ManagementBilirubinDecision Support Systems, ClinicalDeveloping CountriesExchange Transfusion, Whole BloodHumansInfant, NewbornModels, OrganizationalRisk AssessmentSeverity of Illness IndexTime-to-TreatmentBilirubin

Identifiers

PMID26938921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.